Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone

W. L. Betsill Jr, P. P. Rosen, P. H. Lieberman and G. F. Robbins

A follow-up period averaging 21.6 years was obtained for patients with low-grade papillary intraductal carcinoma initially treated only by biopsy between 1940 and 1950. Subsequent carcinoma was diagnosed in the same breast in seven of the ten patients after an average interval of 9.7 years. Six of the seven subsequent carcinomas were invasive. Two of the patients died of metastatic carcinoma and two were known to be alive with metastases when last contacted. Three patients were without carcinoma following mastectomy. When these results were combined with the few reports available in the literature, it appeared that at least 39% of patients with intraductal carcinoma treated by biopsy alone subsequently had clinically evident carcinoma, invariably in the same breat, with an average latent period of about ten years. This was undoubtedly a result of the multicentric nature of the disease in many patients.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Results of 23,810 Cases of Ductal Carcinoma-in-situ
Sumner et al.
Ann. Surg. Oncol. 2007;14:1638-1643.
ABSTRACT | FULL TEXT  

Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians
Armstrong et al.
ANN INTERN MED 2007;146:516-526.
ABSTRACT | FULL TEXT  

Premalignant and In Situ Breast Disease: Biology and Clinical Implications
Arpino et al.
ANN INTERN MED 2005;143:446-457.
ABSTRACT | FULL TEXT  

Conservation of Breast Cancer Molecular Subtypes and Transcriptional Patterns of Tumor Progression Across Distinct Ethnic Populations
Yu et al.
Clin. Cancer Res. 2004;10:5508-5517.
ABSTRACT | FULL TEXT  

Ductal Carcinoma In Situ, Complexities and Challenges
Leonard and Swain
JNCI J Natl Cancer Inst 2004;96:906-920.
ABSTRACT | FULL TEXT  

Ductal Carcinoma in Situ of the Breast
Burstein et al.
NEJM 2004;350:1430-1441.
FULL TEXT  

Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
Lin et al.
Am. J. Pathol. 2003;163:2113-2126.
ABSTRACT | FULL TEXT  

MRI of Occult Breast Carcinoma in a High-Risk Population
Morris et al.
Am. J. Roentgenol. 2003;181:619-626.
ABSTRACT | FULL TEXT  

MR Imaging Findings in the Contralateral Breast of Women with Recently Diagnosed Breast Cancer
Liberman et al.
Am. J. Roentgenol. 2003;180:333-341.
ABSTRACT | FULL TEXT  

Risk Factors for Subsequent Invasive Breast Cancer and Breast Cancer Death after Ductal Carcinoma in Situ: A Population-based Case-Control Study in Sweden
Wärnberg et al.
Cancer Epidemiol. Biomarkers Prev. 2001;10:495-499.
ABSTRACT | FULL TEXT  

The p53 Tumor Suppressor Gene in Ductal Carcinoma in Situ of the Breast
Simpson and Page
Am. J. Pathol. 2000;156:5-6.
FULL TEXT  

Prognosis in Women with a Carcinoma in Situ of the Breast: A Population-based Study in Sweden
Wärnberg et al.
Cancer Epidemiol. Biomarkers Prev. 1999;8:769-774.
ABSTRACT | FULL TEXT  

Ductal Carcinoma in Situ of the Breast
Fonseca et al.
ANN INTERN MED 1997;127:1013-1022.
ABSTRACT | FULL TEXT